The obtained mAbs were then tested for their ability to: (i) recognize the immunizing linear peptides, (ii) specifically detect CD160-TM on paraffin-embedded cells (to further ensure their use on patients' tumor biopsies) and (iii) trigger CD160-TM functional activity on NK cells and therefore induce an amplification of NK cell cytotoxic activity [40]. This evidence concerns the gene CD160 and neoplasm.